A Phase 1/2, open-label study of a modified interleukin-2 fusion protein (IOV 3001) in participants with previously treated, unresectable or metastatic melanom…

Unresectable MelanomaMetastatic MelanomaOcular Melanoma

~Estimated

~$10 – $8,750

Iovance Biotherapeutics, Inc.NCT06940739

Phase 1

A Multicenter Phase Ib/II Study to Evaluate the Safety, Efficacy and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma

This study is being done to find the best dose of an investigational drug called NBM-BMX for people with metastatic uveal melanoma, a type of eye cancer that h…

Metastatic Uveal MelanomaUveal Melanoma, MetastaticUveal Melanoma, Recurrent+2 more

~Estimated

~$10 – $8,750

Novelwise Pharmaceutical CorporationNCT07136181